Prices should remain “stable” in 2022 as buyers’ confidence is expected to remain high and “support for pharmacy acquisitions remains positive”. However, this stability could be rocked by any unexpected sales, the broker suggested in its market report published today (February 7).
Free to registered users
Register to gain full access to C+D and C+D Community content
Already registered?